1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  6. QuickLinks
  1. Launch

Solasta Bio

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2020

Location

Glasgow UK

Primary Industry

Biotechnology

About

Based in Glasgow, UK, and founded in 2020, Solasta Bio provides environmentally friendly products for crop protection. In April 2023, Solasta Bio raised GBP 4 million in pre-series A funding led by returning investor The Yield Lab, with participation from other returning investors SIS Ventures and UK Innovation & Science Seed Fund. New investors Cavallo Ventures, Rubio Impact Ventures, Scottish Enterprise, and individual investors also participated in the round. The company offers modern pest management approaches which include the development of short peptides that disrupt the function of pest species and at the same time it does not affect beneficial insects and vertebrates. The company plans to use the September 2021 funding to develop eco-friendly insecticides.
Current Investors
The Yield Lab, SIS Ventures, UK Innovation & Science Seed Fund

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Bioinformatics
Website
www.solastabio.com
Verticals
Agtech, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.